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Background: During the last decades, outbreaks of hand-foot-
mouthdisease (HFMD)havebeen reported formany times inChina.
The prevention and control of it has become an issue. Presently,
there are no speciﬁc treatments and speciﬁc antiviral drugs or vac-
cines available against non-polio enteroviruses causingHFMD. That
means the risk of infection only can be reduced by good hygiene
practices and early medical attention for children with severe
symptoms. Therefore, early detection and response using math-
ematical statistics method during the epidemics will be helpful for
policy-makers to generate preventive strategies.
Methods & Materials: We proposed a multiple seasonal auto-
regressive integrated moving average model, to forecast the
expected incidence from April 2013 to September 2013 using the
retrospective incidence from January 2008 to December 2012 as
training set, and incidence from January 2013 to March 2013 as
validation set obtained from China Information System for Disease
Control and Prevention (CISDCP). All the procedures were imple-
mented via SAS9.2 system.
Results: After one order of regular differencing and one order
of seasonal differencing, the transformed series achieved station-
ary. The best ﬁtted model was SARIMAwith the lowest value of
Bayesian Information Criterions (BIC). Model parameters had sig-
niﬁcant differences (P <0.05) (Table 1) and the series of residuals
considered to be white noise (=14.59, P >0.05) (Table 2). This indi-
cated that the best ﬁtted model extracted the useful information
of the series. Predictions and observations were very close to each
other and showed a good forecasting performance.
Conclusion: The ARIMA model we proposed can be an effec-
tive way to forecast the incidence cases of HFMD. Detecting the
outbreaks before they happened is the key point of the early detec-
tion and early warning, and that is also the main purpose of our
study. The usefulness of forecasting expected incidence of HFMD
performs not only in giving public-health ofﬁcials a probable trend
of the variability to be expected in the future, but also in detecting
outbreaks and providing probability statements and guidance to
policy makers.
http://dx.doi.org/10.1016/j.ijid.2014.03.983
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Background: Sub-Saharan Africa (SSA) is highly endemic for
HBV infection; yet rapid tests for HBs Antigen (HBsAg) detection
have been poorly validated. Here, using the ﬁeld experience of
the PROLIFICA programme, we assessed the performances of two
HBsAg point-of-care tests (POC) at the community level, in the
Gambia, West Africa
Methods & Materials: The PROLIFICAprogrammeaims at
screening and treating the population for HBV infection in West-
Africa. In Gambian rural communities, we evaluated in parallel two
POCs (Determine®(TM) and VIKIA®,) for HBsAg detection. Dried
Blood Spotswere also systematically collectedduring the screening
and were used for Axsym HBsAg enzyme-linked immunosorbent
assay (ELISA) for conﬁrmation and comparison. Tests performances
were based on Sensitivity (Se), speciﬁcity (Sp), positive and nega-
tive predictive values (PPV, NPV).
Results: 242 persons were screened in the ﬁeld, 30 (12.4%)
patients tested positive with both POCs. Only one participant had
discordant rapid test results. Using Asyxm ELISA, 34(14%) were
HBsAg-positive giving the following Se and Sp for Determine 88.2%
and 99.0% respectively; and 91.2% and 99.0% for Vikia®. The nega-
tive predictive values for both tests exceeded 98%.
Conclusion: In this African rural setting, Determine and Vikia
tests showed slightly lower performances than expected. However,
both tests seem to be sensitive enough to screen easily and quickly
the population for HBV infection in high endemic African settings.
These cheap tests may pave the way for better access to care and
treatment in highly endemic African poor settings.
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